Epigenetic Reprogramming Of Calcified Vascular Smooth Muscle Cells As A Treatment For Vascular Calcification
Funder
National Health and Medical Research Council
Funding Amount
$1,285,195.00
Summary
Pathological hardening of blood vessels, or vascular calcification, is a frequent and deadly complication of many cardiovascular disorders. It is caused by the irreversible change in mature vascular smooth muscle cells (the main cell type in the blood vessel walls) to a bone-forming cell type. We have now identified a new gene that can potentially revert calcified vascular cells back to their physiological state. This represents a promising new approach for treatment of vascular calcification.
Breast Arterial Calcification And Cardiovascular Disease – Exploring Mechanisms And Outcomes.
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Heart disease remains the major of cause of death in women in the Western world and current methods of screening women for heart disease are out-dated and inaccurate. Calcification in the breast arteries that can be diagnosed on screening mammograms has been associated with future heart disease. This may represent a unique way to screen and treat patients for heart disease without the need for additional testing and our research program aims to investigate this.
Development Of A Low-cost, Very Low-radiation Community-based Screening Method For Primary Prevention Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Virtually everyone's life has been affected by cardiovascular disease (CVD) in some way. There are no routine community-based tests to identify asymptomatic CVD due to current tests being invasive, expensive, time-consuming or high radiation exposure. A low cost, very low radiation test from existing machines used for osteoporosis screening can assess a measure of asymptomatic CVD. This fellowship seeks to develop this test for community-based screening strategies.
Calcification of the arteries is a ubiquitous finding in patients with end stage renal failure. It is often mirrored by disturbed bone metabolism. Increasing evidence suggests a close relationship between bone and vascular health. This study aims to determine the role of calciprotein particles as a mediator of calcification in bones and arteries. Translating these findings to renal patients will ultimately contribute to providing a scientific basis for developing treatment for these patients.
IMPROVE-CKD Study: Impact Of A Phosphate Binder On Cardiovascular Disease In Chronic Kidney Disease.
Funder
National Health and Medical Research Council
Funding Amount
$1,596,698.00
Summary
Chronic kidney disease (CKD) is a significant health problem and is associated with an increased risk of cardiovascular (CV) disease. Vascular calcification and arterial stiffness (stiffening of the blood vessels and arteries) are very common in people with CKD, and are linked to increased death from CV events. This study aims to examine the ways in which treatment with a phosphate binder, Lanthanum Carbonate, may reduce vascular calcification and arterial stiffness to decrease CV events.